Efficacy of ceftibuten for pediatric patients undergoing adenotonsillectomy

Area of Science:

• Pediatric Otolaryngology
• Infectious Diseases
• Pharmacology

Background:

• Adenotonsillectomy is the most common pediatric surgery performed by Otolaryngologist Head and Neck Surgeons in Puerto Rico.
• Over 70% of these procedures are done in an ambulatory setting.
• Post-operative antibiotic use is standard practice for most patients.

Purpose of the Study:

• To evaluate the efficacy and safety of ceftibuten in pediatric patients following adenotonsillectomy.
• To assess the tolerance rate of ceftibuten in this patient population.
• To determine the convenience of a once-daily dosing regimen.

Main Methods:

• A prospective study involving 112 pediatric patients who received ceftibuten post-adenotonsillectomy.
• Data collection on adverse events and medication tolerance.
• Assessment of treatment efficacy based on reported outcomes.

Main Results:

• Ceftibuten demonstrated a high tolerance rate of 94% in pediatric patients.
• Only 7 out of 112 patients (approximately 6%) discontinued the medication due to adverse events.
• Twenty adverse events were reported in total, indicating a generally favorable safety profile.

Conclusions:

• Ceftibuten is a safe and effective antibiotic for pediatric patients undergoing adenotonsillectomy.
• The once-daily administration of ceftibuten enhances convenience for children and caregivers.
• Ceftibuten represents a viable therapeutic option for post-operative infection prophylaxis in this surgical context.